Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
about
The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary FibrosisThe Impact of Immunosenescence on Pulmonary DiseaseOxidative stress and pulmonary fibrosisTime-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosisCellular senescence in normal and premature lung aging.Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response.Effect of ulinastatin on paraquat-induced-oxidative stress in human type II alveolar epithelial cells8-Oxoguanine DNA glycosylase-1-mediated DNA repair is associated with Rho GTPase activation and α-smooth muscle actin polymerization.Smoking accelerates aging of the small airway epitheliumThe mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease.Age-related changes in the cellular composition and epithelial organization of the mouse trachea.Blue journal conference. Aging and susceptibility to lung disease.Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling.Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression.Mechanisms of lung aging.Senescent Cells Contribute to the Physiological Remodeling of Aged LungsDifferential Regulation of the Extracellular Cysteine/Cystine Redox State (EhCySS) by Lung Fibroblasts from Young and Old Mice.EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.Inflammaging increases susceptibility to cigarette smoke-induced COPD.Reduction of neutrophilic lung inflammation by inhalation of the compatible solute ectoine: a randomized trial with elderly individuals.Relationship between survival and age in patients with idiopathic pulmonary fibrosis.Aging promotes pro-fibrotic matrix production and increases fibrocyte recruitment during acute lung injury.Cellular senescence mediates fibrotic pulmonary diseaseInfluence of age on wound healing and fibrosis.Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease.The potential of cell-based therapy in lung diseases.Immune response in chronic obstructive pulmonary disease.Lessons from ECLIPSE: a review of COPD biomarkers.An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.The Role of Aging in Idiopathic Pulmonary Fibrosis.Update in Mechanical Ventilation, Sedation, and Outcomes 2014.Biomarkers, the control panel and personalized COPD medicine.Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo.Aging and Lung Disease. Clinical Impact and Cellular and Molecular Pathways.Mitochondrial dysfunction in inflammatory responses and cellular senescence: pathogenesis and pharmacological targets for chronic lung diseases.Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.Soluble extracellular Klotho decreases sensitivity to cigarette smoke induced cell death in human lung epithelial cells.Role of Inflammation and Oxidative Stress in the Pathology of Ageing in COPD: Potential Therapeutic Interventions.miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.
P2860
Q26786969-2D1073ED-0AE1-4B42-A822-A15550D62CE3Q26801157-8BFEC273-680C-4141-AB39-015CCF0F883DQ27024861-00DD2222-29C3-44B6-96E5-0A682A2BEAB2Q28388130-F7FDFD7D-8D12-468A-A4FD-5239FC2DF240Q30317732-DE0C5585-97E6-4FF0-840C-71F1C83AF4E2Q33770974-3B31685F-4C78-4863-8397-6FBF91825F19Q34032222-9CAAC752-41AF-4307-AC57-B790E1310D76Q34145285-5B94CBF8-0B71-45DC-B76D-4469E34C7314Q34304121-B1DF9BF8-1C11-4D38-8EBF-3810AB7983AEQ34352974-D7EC0DC2-CFF4-4967-8C45-10D32751E693Q35133425-3A956107-BBB3-44E4-B516-1F4EDC77F0A7Q35153456-A090001A-5169-47FB-9EE6-00A08296E0F2Q35196768-5DDA58F6-FA51-4E6D-847C-7B383FCDEF39Q35203322-54CB4AAE-D861-46EF-87C5-C26647CE8003Q36164326-F218CE98-8B92-44D7-9013-74A4FADA0F6BQ36885316-02DC2CB6-41A4-4EAC-B922-1629982313C7Q37239707-DD71A6F5-1D5D-4459-9EF6-CB265EAB50CBQ37263917-5798BA06-B372-4493-A775-15A9FA5566C2Q37327421-167FA297-4A7E-476F-8C8C-510288E995C5Q37361474-A850FC8B-0679-475E-B4FD-10686A0FE9B6Q37528351-18220D21-2B85-4B3E-B32A-F90EEA683DCEQ37610880-606EC790-15B9-4F15-8F46-A0A10F297572Q37672706-7285E4B8-86A3-4D5E-B9C1-6A69E926F209Q38057707-E7AAF8EA-24E8-4339-A774-9EE0EFF20A44Q38089196-24F1B807-8265-4294-8EC7-B1D5438F0DF5Q38132249-F401227B-DD07-4AA7-905E-9C0B0C458AA4Q38144104-4CD98B6D-4C0E-4451-BE0D-63CEF42DF439Q38169066-CAEFEC43-C26A-414A-AD8E-2406FC260270Q38399184-7E6FEB9F-D6E9-42D3-8CCA-9C99B77C0E59Q38436607-0A456BEF-6613-4FA2-AF3D-1BAD4092EB38Q38527919-B76B41D6-7900-455C-BEC1-E7CCDDF143B9Q38546748-81DF7A19-7E8F-4643-B552-8801D7D7AFAEQ38591535-DF6DBF7B-AD03-4429-B8D2-2586BCE37F2AQ38642426-DF786598-0C39-411C-B4E5-AE64A1F88125Q38664989-8C12FA0F-2DC9-4927-9C67-6B7D59CE1595Q38836727-936AD71C-661A-4488-9B4E-FF6F00901380Q38837749-4E0CDA8C-9751-4133-8661-971FF7CA7F70Q38861058-F07DCD6B-5349-4E66-84F4-202086D18A94Q38953736-757DD92F-370D-4673-92E4-8AEE4E9ABDA8Q39097324-AF7A84E4-C112-4683-B4E8-D555F7C514D5
P2860
Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Abnormal lung aging in chronic ...... idiopathic pulmonary fibrosis.
@en
type
label
Abnormal lung aging in chronic ...... idiopathic pulmonary fibrosis.
@en
prefLabel
Abnormal lung aging in chronic ...... idiopathic pulmonary fibrosis.
@en
P2860
P1476
Abnormal lung aging in chronic ...... idiopathic pulmonary fibrosis.
@en
P2093
Alvar Agustí
Mauricio Rojas
P2860
P304
P356
10.1164/RCCM.201202-0282PP
P407
P577
2012-05-10T00:00:00Z